General Information of the Ferroptosis Regulator (ID: REG10269)
Regulator Name Lysophosphatidylserine lipase ABHD12
Synonyms
2-arachidonoylglycerol hydrolase ABHD12
    Click to Show/Hide
Gene ID 26090
Regulator Type Protein coding
Uniprot ID Q8N2K0
Sequence
MRKRTEPVALEHERCAAAGSSSSGSAAAALDADCRLKQNLRLTGPAAAEPRCAADAGMKR
ALGRRKGVWLRLRKILFCVLGLYIAIPFLIKLCPGIQAKLIFLNFVRVPYFIDLKKPQDQ
GLNHTCNYYLQPEEDVTIGVWHTVPAVWWKNAQGKDQMWYEDALASSHPIILYLHGNAGT
RGGDHRVELYKVLSSLGYHVVTFDYRGWGDSVGTPSERGMTYDALHVFDWIKARSGDNPV
YIWGHSLGTGVATNLVRRLCERETPPDALILESPFTNIREEAKSHPFSVIYRYFPGFDWF
FLDPITSSGIKFANDENVKHISCPLLILHAEDDPVVPFQLGRKLYSIAAPARSFRDFKVQ
FVPFHSDLGYRHKYIYKSPELPRILREFLGKSEPEHQH

    Click to Show/Hide
Family Serine esterase family
Function
Lysophosphatidylserine (LPS) lipase that mediates the hydrolysis of lysophosphatidylserine, a class of signaling lipids that regulates immunological and neurological processes. Represents a major lysophosphatidylserine lipase in the brain, thereby playing a key role in the central nervous system. Also able to hydrolyze oxidized phosphatidylserine; oxidized phosphatidylserine is produced in response to severe inflammatory stress and constitutes a proapoptotic 'eat me' signal. Also has monoacylglycerol (MAG) lipase activity: hydrolyzes 2-arachidonoylglycerol (2-AG), thereby acting as a regulator of endocannabinoid signaling pathways. Has a strong preference for very-long-chain lipid substrates; substrate specificity is likely due to improved catalysis and not improved substrate binding.

    Click to Show/Hide
HGNC ID
HGNC:15868
KEGG ID hsa:26090
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
Lysophosphatidylserine lipase ABHD12 can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Browse Drug
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis Target of This Regulator [1]
Responsed Disease Fibrosarcoma ICD-11: 2B53
Responsed Drug DO264 Investigative
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
In Vitro Model
HT-1080 cells Fibrosarcoma Homo sapiens CVCL_0317
SU-DHL-5 cells Diffuse large B-cell lymphoma Homo sapiens CVCL_1735
Response regulation DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3 in fibrosarcoma cells, an inhibitor of the lipid peroxidase GPX4.
Fibrosarcoma [ICD-11: 2B53]
In total 1 item(s) under this disease
Experiment 1 Reporting the Ferroptosis-centered Disease Response [1]
Target Regulator Lysophosphatidylserine lipase ABHD12 Protein coding
Responsed Drug DO264 Investigative
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
In Vitro Model
HT-1080 cells Fibrosarcoma Homo sapiens CVCL_0317
SU-DHL-5 cells Diffuse large B-cell lymphoma Homo sapiens CVCL_1735
Response regulation DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3 in fibrosarcoma cells, an inhibitor of the lipid peroxidase GPX4.
DO264 [Investigative]
In total 1 item(s) under this drug
Experiment 1 Reporting the Ferroptosis-centered Drug Response [1]
Drug for Ferroptosis Inducer
Response Target Unspecific Target
Responsed Disease Fibrosarcoma ICD-11: 2B53
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
In Vitro Model
HT-1080 cells Fibrosarcoma Homo sapiens CVCL_0317
SU-DHL-5 cells Diffuse large B-cell lymphoma Homo sapiens CVCL_1735
Response regulation DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3 in fibrosarcoma cells, an inhibitor of the lipid peroxidase GPX4.
References
Ref 1 Blockade of the Lysophosphatidylserine Lipase ABHD12 Potentiates Ferroptosis in Cancer Cells. ACS Chem Biol. 2020 Apr 17;15(4):871-877. doi: 10.1021/acschembio.0c00086. Epub 2020 Mar 20.